Hangzhou Jarvis Medical Technology Co., Ltd.

Hangzhou Jarvis Medical Technology Co. , Ltd. is a Chinese company specializing in dental and oral healthcare instruments, offering a wide range of products designed to enhance dental practice efficiency and patient care. Founded in 2016 and headquartered in Hangzhou, China, Hangzhou Jarvis Medical Technology Co.

, Ltd. focuses on the procurement of essential dental instruments. The company has engaged in three funding deals, with the most recent investment occurring in April 2021 when it raised RMB 100 million in a pre-A funding round led by CCV Capital. The founder, Jin Zou, has a background in the medical technology field, which supports the company's strategic direction.

Hangzhou Jarvis Medical Technology Co. , Ltd. specializes in the procurement of dental and oral healthcare instruments, providing a diverse range of core products that include diagnostic tools, surgical instruments, and preventive care products. These offerings cater to dental professionals, addressing the need for reliable instruments that ensure patient safety and treatment effectiveness.

The company serves dental clinics, hospitals, and supply distributors, primarily in the growing markets of Asia and Europe. The revenue structure of Hangzhou Jarvis Medical Technology Co. , Ltd. is built around a direct-to-consumer model, engaging directly with healthcare providers and institutions.

Clients typically place bulk orders for dental instruments based on their operational needs. This model allows the company to establish long-term partnerships within the dental industry, generating revenue through these direct sales and ensuring clients can obtain essential tools at competitive rates. In April 2021, Hangzhou Jarvis Medical Technology Co. , Ltd.

raised approximately RMB 100 million to support its growth initiatives. The company plans to design and launch new dental products aimed at enhancing operational efficiency for dental practices. Additionally, there are plans to expand into new geographic markets in Asia and Europe, leveraging the recent funding to bolster product development and market entry strategies.